Dasatinib for the treatment of acute lymphoblastic leukaemia [ID386]

  • Discontinued
  • GID-TAG399

Documents

Documents created during the development process.

Leukaemia (dasatinib): final scope

Leukaemia (dasatinib): final matrix

Leukaemia (dasatinib): response to comments on draft scope

Leukaemia (dasatinib): response to comments on the provisional matrix